Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead

Abstract excerpt

The incidence and mortality related to hepatocellular carcinoma (HCC) continue to increase in the United States, with most patients presenting at advanced stages where curative therapy and long-term survival is unlikely. Fortunately, significant progress has been made in identifying the landscape of HCC mutations due to advances in whole genome expression profiling. Drug development has also evolved in recent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Hepatocellular Carcinoma Treatment and Prognosis
• Share to Pancreatic and Hepatic Oncology Research